the test is able to identify early signs of Parkinson’s disease in individuals who have not yet shown clinical symptoms, potentially offering a new pathway for earlier intervention and improved ...

A new discovery from an international collaborative research team has solved the mystery of how cells turn on their recycling ...

Dancing the Blues Away' Seen in Brain Imaging in People With Parkinson's Disease ... have linked disease-related proteins and genes to identify specific cellular pathways responsible for ...

The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients. Weekly injections of the GLP-1 receptor agonist exenatide (Byetta, ...

A new study reveals that entacapone, a drug used to treat Parkinson’s disease, significantly disrupts the gut microbiome by ...

Cambridge researchers are developing implants to help repair brain pathways damaged by Parkinson’s disease. As part of a £69 ...

Researchers suggest drugs that prevent cholesterol from being converted to 24-OHC might therefore be an effective treatment for Parkinson's disease.

Parkinson’s disease is a progressive neurodegenerative ... to the nervous system and the restoration of lost neural pathways. “To date, there’s been little serious investment into ...

Chinese scientists say preventing cholesterol from being converted to 24-OHC might be an effective treatment for Parkinson's ...

Kazia Therapeutics (KZIA) announced a research grant awarded from The Michael J. Fox Foundation for Parkinson’s Research, MJFF, to fund ...

Parkinson’s disease is a neurodegenerative disease that causes nerve cells in the brain to die leading to impaired movement, ...